Related Links
Contact Us
Call 1-888-PEDI-ONC (733-4662) or send an email. Our new patient coordinator will connect you with the right program.
News & Events
2011
December 19, 2011
Targeting EETs to treat cardiovascular disease may prove a double-edged sword
A study documents the connection between increased levels of epoxyeicosatrienoic acids (EET) lipids and cancer growth and metastasis opening the door to a new avenue for cancer treatment. read more
December 16, 2011
Children with cancer in Rwanda get help from Dana-Farber/Children's Hospital Cancer Center physicians
Children with cancer in Rwanda are getting specialized care thanks to a partnership with doctors in the United States, helping to save lives in an area with limited resources. Half of treated lymphoma patients in program survive. read more
December 12, 2011
David Nathan Receives Wallace H. Coulter Award for Lifetime Achievement in Hematology
David G. Nathan, MD, of the Dana-Farber Cancer Institute and Children's Hospital Boston, was presented with the Wallace H. Coulter Award for Lifetime Achievement in Hematology at the 2011 ASH Annual Meeting for his remarkable career combining outstanding teaching, pioneering research, and excellence in clinical care. Beyond Dr. Nathan's lasting influence on his trainees and patients, his research on the inherited disorders of red cells and granulocytes, particularly thalassemia, has had a profound impact on the field of hematology. read more
December 13, 2011
Lymphoma outcomes in children improves by team approach with Rwandan and Boston based physicians
In an African county lacking any specialists in children's cancers, a team approach that "twins” Rwandan physicians with Boston-based pediatric oncologists has shown it can deliver expert, curative care to young patients stricken with lymphoma. read more
December 5, 2011
Pediatric Sickle Cell Disease Patient from Iraq travels to Boston for Stem Cell Transplant
Click here to read about a brave little girl who traveled all the way from Iraq to Boston to get treated for sickle cell disease with a stem cell transplant at Dana-Farber/Children's Hospital Cancer Center.
November 23, 2011
Radiation Sickness Therapy Identified in Study
A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston. read more
October 13, 2011
Dialing up fetal hemoglobin dials down sickle cell disease
Deactivating a single protein corrects sickle cell disease in mice; study opens door to new generation of therapies for this and other blood disorders. read more
July 11, 2011
Epigenetic pathway and new drug show promise in reversing a hard-to-treat childhood cancer
Researchers at Dana-Farber and Children's Hospital Boston have shown that changes in the structure of DNA are responsible for hard-to-treat MLL leukemia – and that it's possible to reverse this process. read more
July 5, 2011
DF/CHCC restructures inpatient and consult services to benefit patients
Dana-Farber/Children's Hospital Cancer Center recently restructured its inpatient oncology and consult services to better care for patients. read more
June 22, 2011
The cell from hell: Can we outsmart cancer stem cells?
Some scientists still debate the existence of cancer stem cells – rare cells that can singlehandedly perpetuate a tumor, and possibly make it more aggressive. read more
June 13, 2011
Our patients' stories: Taking on cancer with a smile
When Sara Cepeda's daughter Ariana was just two months old, she made a terrifying discovery while changing the small girl's diaper. As Sara looked down at her baby on the changing table, she was horrified to see that Ariana's entire midsection was covered in bruises. read more
June 5, 2011
Neuroblastoma News from ASCO 2011
Lisa Diller, MD, Associate Professor of Pediatrics at Harvard Medical School and Clinical Director of Pediatric Oncology at the Dana-Farber/Children's Hospital Cancer Center discusses the neuroblastoma study in this video. read more
May 27, 2011
A new start for gene therapy for "bubble boy" disease: First U.S.-treated patient doing well
Agustín, born in Argentina, has a form of X-linked Severe Combined Immunodeficiency, or SCID-X1, better known as "bubble boy disease." read more
May 17, 2011
U.S. News rates Dana-Farber/Children's Hospital Cancer Center as top pediatric cancer hospital
U.S. News & World Report has ranked Children's Hospital Boston and Dana-Farber Cancer Institute as the top pediatric cancer hospital in the United States in its 2011-12 Best Children's Hospitals guide. read more
April 21, 2011
Moving gene therapy into high gear, Vector
Gene therapy, still experimental but beginning to enter the clinic, attempts to utilize advanced molecular methods to treat and even reverse genetic diseases. read more
April 8, 2011
Satisfaction guaranteed at Children's Stem Cell program, Children's News
In an effort to make their hospital stay as easy as possible for the program's families, Lehmann and her team have enacted an innovative solution. read more
March 28, 2011
Special needs, special care, The Boston Globe
Innovative team approach helps families of seriously ill children that struggle to balance blessings and burdens of treatment. read more
March 10, 2011
Number of U.S. cancer survivors grows to nearly 12 million, underscores need for survivorship care
The number of cancer survivors reported by the Centers for Disease Control and Prevention and the National Cancer Institute demonstrates how important it is to provide survivors with the care and follow-up they need to live healthy lives, says Dana-Farber's Dr. Lisa Diller. view video
February 22, 2011
Dana-Farber/Children's Hospital Cancer Center physicians recognized as 'Top Doctors' in Boston area
Four Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) cancer specialists were recognized by Boston magazine for being among the area's top physicians.
